产品展示
Influenza-B Victoria/乙型流感病毒Victoria 504/00
点击次数：349发布时间：2012/11/5 18:59:54
更新日期：2024/10/16 16:00:43
所 在 地：美洲
产品型号：
优质供应
详细内容
慧嘉生物您实验身边的好伙伴
为客户提供“品质的产品”和“*优质的服务”
AssayBiotech CUSABIO Immunoway Santa Abcam Cst jackson Pierce Sigma Amresco Qiagen Cayman abnova millipore invitrogen merk ebioscience prospec
欢迎广大客户咨询，另有大量宣传海报和小礼品赠送。
Q Q：
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Influenza-B Victoria/乙型流感病毒Victoria 504/00
产品编号：IHA-018
产品规格：10μg/50μg/1mg
Introduction Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase.
The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza B virus, immunogen for antibody production.
Tested with anti-influenza B monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
产品规格：10μg/50μg/1mg
| Introduction | Influenzavirus B is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift ａnd reassortment. Influenza-B virus evolves slower than A viruses ａnd faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, ａnd a polymerasecomplex. Influenza B is sometimes spherical ａnd sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin ａnd neuraminidase. The Influenza B virus is 14648 nucleotideslong ａnd consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, ａnd the nucleocapsids are surrounded by one envelope. |
| Description | Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. |
| Inactivation | Thimerosal ａnd beta propiolactone treatment This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. |
| Physical Appearance | Sterile Filtered colorless solution. |
| Formulation | The B/ Victoria /53/99solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. |
| Stability | B/Victoria/504/00 although stable 4°C for 4 weeks, should be stored desiccated below -18°C. Please prevent freeze-thaw cycles. |
| Immunological Activity | Serological studies of influenza B virus, immunogen for antibody production. Tested with anti-influenza B monoclonal antibodies in ELISA. |
| Purity | Greater than 90.0% as determined by SDS-PAGE. |
| Usage | ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals. |
